Literature DB >> 15322500

Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.

Ernest Beutler1, Lisa Beutler, Carol West.   

Abstract

Patients with Gaucher disease have a deficiency of the lysosomal acid beta-glucosidase. The phenotypes of genotypically identical patients with Gaucher disease may differ markedly. We have examined the possibility that polymorphisms in another beta-glucosidase are responsible for this variability in the phenotype. Sequence analysis of the gene encoding cytosolic beta-glucosidase (GBA3) from 4 chromosomes revealed the presence of 4 single-nucleotide substitutions: c.316 G -->A (D106N), c.1353A-->G (Y451Y), c.1368T-->A (Y456X), and c.1540 to 1541AG -->T in the 3' untranslated region. We examined the DNA from 62 patients with Gaucher disease who were homozygous for the 1226A-->G (N370S) mutation and from 542 control subjects from various populations for these polymorphisms. Six of the possible 16 haplotypes were found, and none was over- or underrepresented among patients with the severe Gaucher disease phenotypes compared with those from patients with mild phenotypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322500     DOI: 10.1016/j.lab.2004.03.013

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

Review 1.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

Review 2.  Neuropathic Gaucher disease.

Authors:  Gregory M Pastores
Journal:  Wien Med Wochenschr       Date:  2010-12

Review 3.  GBA Variants and Parkinson Disease: Mechanisms and Treatments.

Authors:  Laura Smith; Anthony H V Schapira
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

4.  Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.

Authors:  C Fairley; A Zimran; M Phillips; M Cizmarik; J Yee; N Weinreb; S Packman
Journal:  J Inherit Metab Dis       Date:  2008-11-03       Impact factor: 4.982

5.  Whole genome sequence analyses of brain imaging measures in the Framingham Study.

Authors:  Chloé Sarnowski; Claudia L Satizabal; Charles DeCarli; Achilleas N Pitsillides; L Adrienne Cupples; Ramachandran S Vasan; James G Wilson; Joshua C Bis; Myriam Fornage; Alexa S Beiser; Anita L DeStefano; Josée Dupuis; Sudha Seshadri
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

6.  Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.

Authors:  Susan Elliott; Norman Buroker; Jason J Cournoyer; Anna M Potier; Joseph D Trometer; Carole Elbin; Mack J Schermer; Jaana Kantola; Aaron Boyce; Frantisek Turecek; Michael H Gelb; C Ronald Scott
Journal:  Mol Genet Metab       Date:  2016-05-20       Impact factor: 4.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.